Haibao Shang

1.1k total citations · 1 hit paper
12 papers, 754 citations indexed

About

Haibao Shang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Haibao Shang has authored 12 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Haibao Shang's work include Peroxisome Proliferator-Activated Receptors (2 papers), Cardiac Ischemia and Reperfusion (2 papers) and Diabetes Treatment and Management (2 papers). Haibao Shang is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (2 papers), Cardiac Ischemia and Reperfusion (2 papers) and Diabetes Treatment and Management (2 papers). Haibao Shang collaborates with scholars based in China, United States and France. Haibao Shang's co-authors include Yuli Liu, Rui‐Ping Xiao, Xinli Hu, Xiuqin Zhang, Yan Zhang, Ting Zhang, Jiaojiao Guo, Hongkun Wu, Fengxiang Lv and Chunmei Cao and has published in prestigious journals such as Circulation, Nature Medicine and Nature Communications.

In The Last Decade

Haibao Shang

10 papers receiving 750 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress–induced myocardial necroptosis

2016 622 citations Ting Zhang, Yan Zhang et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haibao Shang China	7	503	182	126	121	106	12	754
Klitos Konstantinidis United States	5	562 1.1×	199 1.1×	145 1.2×	174 1.4×	59 0.6×	10	846
Dulguun Amgalan United States	7	549 1.1×	182 1.0×	129 1.0×	121 1.0×	87 0.8×	9	858
Delphine Baetz France	16	535 1.1×	226 1.2×	108 0.9×	163 1.3×	68 0.6×	32	820
Huairui Shi China	13	442 0.9×	202 1.1×	76 0.6×	81 0.7×	180 1.7×	19	725
Vladimir Kaplinskiy United States	4	389 0.8×	171 0.9×	103 0.8×	123 1.0×	56 0.5×	4	688
Corinne Berthonneche Switzerland	17	467 0.9×	327 1.8×	115 0.9×	117 1.0×	61 0.6×	23	882
Xi Jiang China	14	366 0.7×	187 1.0×	200 1.6×	37 0.3×	173 1.6×	27	740
S A Mohammed Switzerland	17	465 0.9×	206 1.1×	67 0.5×	38 0.3×	78 0.7×	54	837
Ke‐Qiong Deng China	16	372 0.7×	249 1.4×	139 1.1×	29 0.2×	164 1.5×	32	787
Eduardo Mascareno United States	16	405 0.8×	269 1.5×	58 0.5×	82 0.7×	105 1.0×	28	765

Countries citing papers authored by Haibao Shang

Since Specialization

Citations

This map shows the geographic impact of Haibao Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibao Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibao Shang more than expected).

Fields of papers citing papers by Haibao Shang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haibao Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibao Shang. The network helps show where Haibao Shang may publish in the future.

Co-authorship network of co-authors of Haibao Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Haibao Shang. A scholar is included among the top collaborators of Haibao Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haibao Shang. Haibao Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Wang, Zeyuan, Rui Ma, Junxia Zhang, et al.. (2025). Oestrogen-related receptor γ in sepsis-induced cardiomyopathy: role of cardiomyocyte subtype conversion. European Heart Journal.

Zhang, Junxia, Mao Zhang, Li Fan, et al.. (2025). Danhong Injection targets CaMKII through Dihydrotanshinone I to alleviate cardiomyocyte death and inflammation in viral myocarditis. Science China Life Sciences. 69(3). 814–831.

Zhang, Junxia, Jiayi Li, F. Li, et al.. (2025). Intracellular L-PGDS–Derived 15d-PGJ2 Inhibits CaMKII Through Lipoxidation to Alleviate Cardiac Ischemia/Reperfusion Injury. Circulation. 152(1). 41–57. 2 indexed citations

Chen, Wenli, Jian Wu, Wen Zheng, et al.. (2023). Blocking IL-6 signaling improves glucose tolerance via SLC39A5-mediated suppression of glucagon secretion. Metabolism. 146. 155641–155641. 13 indexed citations

Zhou, Xiaohai, Chenyang Zhang, Xueying Wu, et al.. (2022). Dusp6 deficiency attenuates neutrophil-mediated cardiac damage in the acute inflammatory phase of myocardial infarction. Nature Communications. 13(1). 6672–6672. 23 indexed citations

Wang, Jue, Wen Zheng, Shuquan Zheng, et al.. (2022). Targeting ANGPTL3 by GalNAc-conjugated siRNA ANGsiR10 lowers blood lipids with long-lasting and potent efficacy in mice and monkeys. Molecular Therapy — Nucleic Acids. 31. 68–77. 11 indexed citations

Zhang, Mao, Junxia Zhang, Jin Li, et al.. (2022). CaMKII-δ9 Induces Cardiomyocyte Death to Promote Cardiomyopathy and Heart Failure. Frontiers in Cardiovascular Medicine. 8. 820416–820416. 5 indexed citations

Zheng, Wen, Yu‐Li Liu, Haibao Shang, et al.. (2018). Characterization of spontaneously-developed non-alcoholic fatty liver disease in aged rhesus monkeys. Diabetology & Metabolic Syndrome. 10(1). 68–68. 7 indexed citations

Xiao, Yao, Jue Wang, Ning Hou, et al.. (2018). Dynamic changes in insulin and glucagon during disease progression in rhesus monkeys with obesity‐related type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 21(5). 1111–1120. 8 indexed citations

10.

Wang, Xiaoxia, Chun Song, Xiao Albert Zhou, et al.. (2017). Mitochondria Associated MicroRNA Expression Profiling of Heart Failure. BioMed Research International. 2017. 1–10. 59 indexed citations

11.

Zhang, Ting, Yan Zhang, Jin Li, et al.. (2016). CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress–induced myocardial necroptosis. Nature Medicine. 22(2). 175–182. 622 indexed citations breakdown →

12.

Zhang, Yan, Wen Zheng, Yuli Liu, et al.. (2016). Eplerenone restores 24-h blood pressure circadian rhythm and reduces advanced glycation end-products in rhesus macaques with spontaneous hypertensive metabolic syndrome. Scientific Reports. 6(1). 23957–23957. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact